TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
EMPLOYEES
Verto Pharma AB
Closing information (x1000 SEK)
| Closing information | 2022/12 | 2021/12 | 2020/12 |
| Turnover |
1,213
|
2,385
|
1,492 |
| Financial expenses |
0
|
0
|
0 |
| Earnings before taxes |
523
|
1,239
|
567 |
| EBITDA |
533
|
1,256
|
577 |
| Total assets |
5,964
|
5,474
|
4,398 |
| Current assets |
3,443
|
2,941
|
1,884 |
| Current liabilities |
1,240
|
773
|
404 |
| Equity capital |
4,492
|
4,433
|
3,755 |
| - share capital |
50
|
50
|
50 |
| Employees (average) |
1
|
1
|
1 |
Financial ratios
| Fiscal year | 2022/12 | 2021/12 | 2020/12 |
| Solvency |
75.3%
|
81.0%
|
85.4% |
| Turnover per employee |
1,213
|
2,385
|
1,492 |
| Profit as a percentage of turnover |
43.1%
|
51.9%
|
38.0% |
| Return on assets (ROA) |
8.8%
|
22.6%
|
12.9% |
| Current ratio |
277.7%
|
380.5%
|
466.3% |
| Return on equity (ROE) |
11.6%
|
27.9%
|
15.1% |
| Change turnover |
-1,172
|
893
|
1,209 |
| Change turnover % |
-49%
|
60%
|
427% |
| Chg. No. of employees |
0
|
0
|
0 |
| Chg. No. of employees % |
0%
|
0%
|
0% |
Total value of public sale
| Fiscal year | 2022/12 | 2021/12 | 2020/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.